[Anticancer effect of peplomycin on advanced recurrent breast cancer]. 1984

Y Nakanishi, and Y Hata, and N Sato, and A Kawamura, and T Uemura, and M Hasegawa, and K Miyakawa, and T Nakamura, and M Kawai, and K Kawamoto

The anticancer effect of peplomycin (PEP) on advanced or recurrent breast cancer was investigated clinically and histopathologically. Stage III (n = 12), Stage IV (n = 2) and recurrent (n = 6) breast cancer patients were treated with PEP of which 10 mg were administered 3 times a week for 3 weeks either intravenously (n = 13) or intra-arterially (n = 7, via a catheter inserted into the subclavian artery). A decrease in tumor volume of more than 50% was obtained in 38.5% of the intravenously treated cases and in 28.6% the intra-arterially treated cases. Histologically, grades II b and III were observed in 66% of patients according to Oboshi's classification. These investigations suggest the effectiveness of PEP on breast cancer.

UI MeSH Term Description Entries
D007269 Injections, Intra-Arterial Delivery of drugs into an artery. Injections, Intraarterial,Intra-Arterial Injections,Intraarterial Injections,Injection, Intra-Arterial,Injection, Intraarterial,Injections, Intra Arterial,Intra Arterial Injections,Intra-Arterial Injection,Intraarterial Injection
D007275 Injections, Intravenous Injections made into a vein for therapeutic or experimental purposes. Intravenous Injections,Injection, Intravenous,Intravenous Injection
D008207 Lymphatic Metastasis Transfer of a neoplasm from its primary site to lymph nodes or to distant parts of the body by way of the lymphatic system. Lymph Node Metastasis,Lymph Node Metastases,Lymphatic Metastases,Metastasis, Lymph Node
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009364 Neoplasm Recurrence, Local The local recurrence of a neoplasm following treatment. It arises from microscopic cells of the original neoplasm that have escaped therapeutic intervention and later become clinically visible at the original site. Local Neoplasm Recurrence,Local Neoplasm Recurrences,Locoregional Neoplasm Recurrence,Neoplasm Recurrence, Locoregional,Neoplasm Recurrences, Local,Recurrence, Local Neoplasm,Recurrence, Locoregional Neoplasm,Recurrences, Local Neoplasm,Locoregional Neoplasm Recurrences,Neoplasm Recurrences, Locoregional,Recurrences, Locoregional Neoplasm
D001761 Bleomycin A complex of related glycopeptide antibiotics from Streptomyces verticillus consisting of bleomycin A2 and B2. It inhibits DNA metabolism and is used as an antineoplastic, especially for solid tumors. BLEO-cell,Blanoxan,Blenoxane,Bleolem,Bleomicina,Bleomycin A(2),Bleomycin A2,Bleomycin B(2),Bleomycin B2,Bleomycin Sulfate,Bleomycins,Bleomycinum Mack,Bléomycine Bellon,BLEO cell,BLEOcell,Bellon, Bléomycine,Mack, Bleomycinum,Sulfate, Bleomycin
D001943 Breast Neoplasms Tumors or cancer of the human BREAST. Breast Cancer,Breast Tumors,Cancer of Breast,Breast Carcinoma,Cancer of the Breast,Human Mammary Carcinoma,Malignant Neoplasm of Breast,Malignant Tumor of Breast,Mammary Cancer,Mammary Carcinoma, Human,Mammary Neoplasm, Human,Mammary Neoplasms, Human,Neoplasms, Breast,Tumors, Breast,Breast Carcinomas,Breast Malignant Neoplasm,Breast Malignant Neoplasms,Breast Malignant Tumor,Breast Malignant Tumors,Breast Neoplasm,Breast Tumor,Cancer, Breast,Cancer, Mammary,Cancers, Mammary,Carcinoma, Breast,Carcinoma, Human Mammary,Carcinomas, Breast,Carcinomas, Human Mammary,Human Mammary Carcinomas,Human Mammary Neoplasm,Human Mammary Neoplasms,Mammary Cancers,Mammary Carcinomas, Human,Neoplasm, Breast,Neoplasm, Human Mammary,Neoplasms, Human Mammary,Tumor, Breast
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

Y Nakanishi, and Y Hata, and N Sato, and A Kawamura, and T Uemura, and M Hasegawa, and K Miyakawa, and T Nakamura, and M Kawai, and K Kawamoto
July 1983, Gan to kagaku ryoho. Cancer & chemotherapy,
Y Nakanishi, and Y Hata, and N Sato, and A Kawamura, and T Uemura, and M Hasegawa, and K Miyakawa, and T Nakamura, and M Kawai, and K Kawamoto
August 1984, Nihon Gan Chiryo Gakkai shi,
Y Nakanishi, and Y Hata, and N Sato, and A Kawamura, and T Uemura, and M Hasegawa, and K Miyakawa, and T Nakamura, and M Kawai, and K Kawamoto
December 1984, Gan to kagaku ryoho. Cancer & chemotherapy,
Y Nakanishi, and Y Hata, and N Sato, and A Kawamura, and T Uemura, and M Hasegawa, and K Miyakawa, and T Nakamura, and M Kawai, and K Kawamoto
January 1981, The Prostate. Supplement,
Y Nakanishi, and Y Hata, and N Sato, and A Kawamura, and T Uemura, and M Hasegawa, and K Miyakawa, and T Nakamura, and M Kawai, and K Kawamoto
January 1987, Cancer treatment reports,
Y Nakanishi, and Y Hata, and N Sato, and A Kawamura, and T Uemura, and M Hasegawa, and K Miyakawa, and T Nakamura, and M Kawai, and K Kawamoto
May 1993, Cancer,
Y Nakanishi, and Y Hata, and N Sato, and A Kawamura, and T Uemura, and M Hasegawa, and K Miyakawa, and T Nakamura, and M Kawai, and K Kawamoto
March 1992, Nihon Sanka Fujinka Gakkai zasshi,
Y Nakanishi, and Y Hata, and N Sato, and A Kawamura, and T Uemura, and M Hasegawa, and K Miyakawa, and T Nakamura, and M Kawai, and K Kawamoto
November 2013, Gan to kagaku ryoho. Cancer & chemotherapy,
Y Nakanishi, and Y Hata, and N Sato, and A Kawamura, and T Uemura, and M Hasegawa, and K Miyakawa, and T Nakamura, and M Kawai, and K Kawamoto
August 1990, Nihon Gan Chiryo Gakkai shi,
Y Nakanishi, and Y Hata, and N Sato, and A Kawamura, and T Uemura, and M Hasegawa, and K Miyakawa, and T Nakamura, and M Kawai, and K Kawamoto
July 1987, Gan to kagaku ryoho. Cancer & chemotherapy,
Copied contents to your clipboard!